Back to Results
First PageMeta Content
TLR 2 / Kidney transplantation / Toll-like receptor / Medicine / Biology / Opsona Therapeutics


OPSONA THERAPEUTICS One line pitch: Dublin based Irish Biotech Company with focus on development of anti-inflammatory therapeutics targeting major disease areas supported by a blue chip investor consortium. Market Analy
Add to Reading List

Document Date: 2015-03-26 11:01:38

Open Document

File Size: 212,25 KB

Share Result on Facebook

City

Dublin / /

Company

Opsona Therapeutics Ltd / Baxter Ventures / BB Biotech Ventures / Irish Biotech Company / Inventages Venture Capital / Amgen Ventures / Fountain Healthcare Partners / EMBL Ventures / Seizinger Bernd / /

Currency

USD / EUR / /

/

Event

FDA Phase / /

Facility

Trinity College / /

IndustryTerm

pharmaceutical targets / /

MedicalCondition

several cancer / burn / disease / Kidney Graft Dysfunction / kidney failure / myocardial infarction / inflammatory conditions / Myocardial Infarct / human diseases / infections / inflammatory diseases / /

MedicalTreatment

renal transplantation / organ transplants / renal transplant / /

Organization

Novartis Venture Fund / Trinity College in Dublin / Roche Venture Fund / Genen Fund / /

Person

Reilly Mary / Welschof Martin / Dalton Conor / /

Position

CEO / Chairman / VP of Pharmaceutical Development & Operations Dalton Conor Finance / Director OPN-305 Finance / VP of Pharmaceutical Development & Operations / /

Product

ECD / OPN-305 / /

Technology

transplantation / /

URL

www.opsona.com / /

SocialTag